跳至主要内容
临床试验/NCT00861081
NCT00861081已完成不适用

RCT of an Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to "Stay Within the Guidelines" (SUSTAIN)

University of California, Los Angeles10 个研究点 分布在 1 个国家目标入组 410 人开始时间: 2010年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
410
试验地点
10
主要终点
Blood Pressure

研究概览

简要总结

The purpose of this study is to test a newly developed outpatient care intervention called SUSTAIN (Systematic Use of Stroke Averting Interventions) for improving delivery of stroke preventive services at Los Angeles County hospitals and to measure the costs of running such an intervention.

详细描述

Patients randomized to SUSTAIN will participate in group clinics about stroke, given self-management tools about stroke, and will be called by nurse practitioners to coordinate their stroke care. Patients randomized to the control arm will be mailed educational materials about stroke. Subjects in either arm are eligible to receive their usual source of care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of LAC+USC, Rancho Los Amigos, Olive View-UCLA, or Harbor-UCLA
  • Patients who have had an acute transient ischemic attack (TIA) or ischemic stroke or carotid procedure within the last six months
  • English or Spanish speaking
  • At least 40 years of age
  • Capable of giving informed consent (no proxies will be used to obtain consent)
  • Blood pressure not optimally controlled (>120/80, at least 72 hours post-stroke)

排除标准

  • Age 39 years or younger
  • Hemorrhagic stroke
  • Patients with severe global disability which would preclude him/her from participating in group clinics
  • Patients with advanced dementia

研究组 & 干预措施

1: Care management

Experimental

干预措施: Care Management (Behavioral)

2: Written Materials

Active Comparator

干预措施: Written Materials (Behavioral)

结局指标

主要结局

Blood Pressure

时间窗: 12 months

Blood pressure at 12 months will be the primary outcome. Blood pressure will also be measured at baseline and at the 3-month mark to track blood pressure during the entire participation period.

次要结局

  • Lipid levels(12 month)
  • Medication Adherence(8 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barbara Vickrey, MD, MPH

Principal Investigator

University of California, Los Angeles

研究点 (10)

Loading locations...

相似试验